Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
AZRX

Overview Financials Analysis Smart Money

AzurRx BioPharma, Inc.

AZRX · NASDAQ

Analyze with AI

Filings1

Total reported value$0.0

Manager	Shares	Value	Change
LADENBURG THALMANN FINANCIAL SERVICES INC.	0	$0.0	+100.0%

SymbolAZRX

Market Cap$3.4M

IPO Date2016-10-11

CEOJames Sapirstein

Employees12

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Crown ElectroKinetics Corp.

CRKN

$0.11

+115.69%

Aimei Health Technology Co., Ltd

AFJK

$52.23

+100.81%

Athira Pharma, Inc.

ATHA

$6.72

+62.52%

Sable Offshore Corp.

SOC

$8.25

+56.25%

Zeta Network Group

ZNB

$1.02

+55.73%

Peers

Lisata Therapeutics, Inc.

LSTA · NASDAQ

$2.01

+0.50%

Onconetix, Inc.

ONCO · NASDAQ

$1.84

-3.66%

Unity Biotechnology, Inc.

UBX · NASDAQ

$0.2001

+92.77%

Atreca, Inc.

BCEL · NASDAQ

$0.09

-1.32%

Idera Pharmaceuticals, Inc.

IDRA · NASDAQ

$0.425

-23.04%

VivoSim Labs, Inc.

VIVS · NASDAQ

$1.93

+2.66%

RVL Pharmaceuticals plc

RVLP · NASDAQ

$0.0282

-32.05%

Gritstone bio, Inc.

GRTS · NASDAQ

$0.0322

-31.78%

Altamira Therapeutics Ltd.

CYTO · NASDAQ

$0.30

+100.00%

Q32 Bio Inc.

QTTB · NASDAQ

$3.03

+5.21%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.